"World's Most Complete Market Research Reports Repository"

Global Oncology Drugs Market Research Report 2011-2023

Summary
The global Oncology Drugs market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Oral Therapy
Injectable Therapy
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis A.G
Laboratrio Cristlia
Medley Genomics
F. Hoffmann-La Roche Ltd
Icon Plc.
Sanofi S.A.
Laboratoires Pierre Fabre
Eurofarma Laboratrios S.A.
Ach Laboratrios Farmacuticos S.A.
Laboratorios IMA
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Targeted Therapy
Chemotherapy
Hormonal Therapy
Biologic Therapy
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Oral Therapy
1.2.1.2 Injectable Therapy
1.2.2 by Application
1.2.2.1 Targeted Therapy
1.2.2.2 Chemotherapy
1.2.2.3 Hormonal Therapy
1.2.2.4 Biologic Therapy
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Oral Therapy Market, 2011-2016
4.1.2 Injectable Therapy Market, 2011-2016
4.2 Market Forecast
4.2.1 Oral Therapy Market Forecast, 2017-2022
4.2.2 Injectable Therapy Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Targeted Therapy Market, 2011-2016
5.1.2 Chemotherapy Market, 2011-2016
5.1.3 Hormonal Therapy Market, 2011-2016
5.1.4 Biologic Therapy Market, 2011-2016
5.2 Market Forecast
5.2.1 Targeted Therapy Market Forecast, 2017-2022
5.2.2 Chemotherapy Market Forecast, 2017-2022
5.2.3 Hormonal Therapy Market Forecast, 2017-2022
5.2.4 Biologic Therapy Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Novartis A.G
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Laboratrio Cristlia
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Medley Genomics
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 F. Hoffmann-La Roche Ltd
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Icon Plc.
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Sanofi S.A.
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Laboratoires Pierre Fabre
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Eurofarma Laboratrios S.A.
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Ach Laboratrios Farmacuticos S.A.
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 Laboratorios IMA
8.10.1 Profile
8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion

Table Product Specifications of Oncology Drugs
Table Products Segment of Oncology Drugs
Table Oral Therapy Overview
Table Injectable Therapy Overview
Table Global Oncology Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Oncology Drugs
Table Targeted Therapy Overview
Table Chemotherapy Overview
Table Hormonal Therapy Overview
Table Biologic Therapy Overview
Table Global Oncology Drugs Market by Application, 2011-2022 (USD Million)
Table Global Oncology Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Oncology Drugs
Table Market Dynamics
Table Policy of Oncology Drugs
Table GDP of Major Countries
Table Oral Therapy CAGR by Revenue and Volume, 2011-2016
Table Injectable Therapy CAGR by Revenue and Volume, 2011-2016
Table Oral Therapy CAGR by Revenue and Volume, 2012-2022
Table Injectable Therapy CAGR by Revenue and Volume, 2012-2022
Table Targeted Therapy CAGR by Revenue and Volume, 2011-2016
Table Chemotherapy CAGR by Revenue and Volume, 2011-2016
Table Hormonal Therapy CAGR by Revenue and Volume, 2011-2016
Table Biologic Therapy CAGR by Revenue and Volume, 2011-2016

Choose License Type